|
|
|
|
LEADER |
01302nam a2200253 u 4500 |
001 |
EB002001282 |
003 |
EBX01000000000000001164183 |
005 |
00000000000000.0 |
007 |
tu||||||||||||||||||||| |
008 |
210907 r ||| eng |
245 |
0 |
0 |
|a Telemedicine for the treatment of urgent conditions
|h Elektronische Ressource
|b a review of clinical effectiveness, cost-effectiveness, and guidelines
|
246 |
3 |
1 |
|a Emergency telemedicine
|
260 |
|
|
|a Ottawa (ON)
|b Canadian Agency for Drugs and Technologies in Health
|c 2015, 2015
|
300 |
|
|
|a 1 PDF file (14 pages)
|b illustration
|
505 |
0 |
|
|a Includes bibliographical references
|
710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|b Rapid Response Service
|
710 |
2 |
|
|a Canadian Agency for Drugs and Technologies in Health
|
041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
490 |
0 |
|
|a Rapid response report: summary with critical appraisal
|
500 |
|
|
|a Title from PDF caption. - "7 October 2015."
|
856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK326842
|3 Volltext
|
082 |
0 |
|
|a 610
|
520 |
|
|
|a This report aims to review recent evidence and relevant practice guidelines surrounding the use of telemedicine with a video component in the emergency setting, for conditions other than stroke
|